Marshall BioResources is a commercial animal breeder that supplies animals for biomedical research. Its recent lobbying—reported in one filing totaling $50,000 and done through Chamber Hill Strategies—focused on health and pre-clinical research issues, including the FDA Modernization Act (S. 5048/H.R. 7248). This suggests it lobbied Congress about rules affecting pre-clinical testing that involve research animals.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ABIGAIL ROSE
The latest disclosures for this client.
CHAMBER HILL STRATEGIES
Q3CHAMBER HILL STRATEGIES
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CHAMBER HILL STRATEGIES
JENNIFER BELL
CHAMBER HILL STRATEGIES
JENNIFER HOLLAND
CHAMBER HILL STRATEGIES
KATHRYN MEADOWS
CHAMBER HILL STRATEGIES
ZACHARY SCHULZ
CHAMBER HILL STRATEGIES